(News Bulletin 247) – On the basis of a graphical argument, News Bulletin 247 analysts selected MEDINCELL for active investors.
KEY GRAPHIC ELEMENTS
The graphical analysis of daily data of the MEDINCELL stock makes it possible to identify a medium-term upward trend. In the short term, the action of the specialist in injectable treatments with prolonged effectiveness completes a corrective phase. Among the dominant graphical factors, we noted the presence of an upward channel on MEDINCELL share prices. The title has just made contact with the lower limit of this vast corridor. With in addition a positive message sent by the relative strength index.
FORECAST
Looking at the key chart factors we mentioned, our view is bullish on MEDINCELL stock in the near term.
Active investors will take a purchase position on the MEDINCELL stock at a price of €15.80 with a target of €19,950 in their sights. They will protect their capital by placing a stop at €14,230.
News Bulletin 247 advice
DAILY DATA CHART
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
